Nivolumab 240mg/24ml solution for infusion vials
NHS hospitals in England used £138,888,286 of indicative cost of Nivolumab 240mg/24ml solution for infusion vials in the 12 months to July 2026, about 0.5% of all hospital medicines spend. That is down 36.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Nivolumab 240mg/24ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Nivolumab 240mg/24ml solution for infusion vials most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Clatterbridge Cancer Centre Nhs Ft | £13,674,486 |
| Univ Hpl B/Ham Nhs Foundation Trust | £5,645,152 |
| Cambridge Univ Hosp Nhs Foundation Trust | £4,781,528 |
| Royal Surrey County Hosp Nhs Found Trust | £4,481,366 |
| South Tees Hosp Nhs Foundation Trust | £4,028,490 |
| University Hpls Of Leicester Nhs Trust | £3,809,951 |
| Guy's & St Thomas' Nhs Foundation Trust | £3,794,153 |
| Southend Univ Hosp Nhs Foundation Trust | £3,605,894 |
| Sheffield Teaching Hospitals Nhs Trust | £3,575,614 |
| University Hospital Southampton Nhs Ft | £3,255,705 |
The primary-care picture
Nivolumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Nivolumab medicine page.